Explore our drug delivery technology platforms
We are a world leader in pharmaceutical excipients, vaccine adjuvants and lipid delivery systems for human and veterinary applications.
Small Molecule Delivery
We offer high purity, multi-compendial, pharmaceutical excipients for small molecule drug delivery. Our portfolio of high purity excipient products and speciality chemistries solve formulation challenges and enhance drug delivery across a variety of administration routes and dosage forms.
Protein Delivery
We collaborate with you to provide tailored excipient solutions, drawing on our expertise and product portfolio to speed up formulation development and time to market. Enabling drug delivery through a wide range of highly purified excipients to improve protein formulation stability.
Nucleic Acid Delivery
We develop and manufacture innovative lipids of unparalleled purity to solve the stability and delivery issues associated with mRNA for use in vaccines and next-generation therapeutics.
Adjuvant Systems
Your partner for modern vaccine development. Our unique GMP portfolio and outstanding expertise can meet your adjuvant needs. Collaborate with our scientists to create the vaccines of tomorrow.
How we empower biologics delivery
Explore recent blogs:
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=A3F1E1F41A1C690A537D793D09D9F2EA)
QbD Formulation Development
Formulation development is a pivotal stage in the life cycle of a therapeutic drug product, it can be the make or break of it. The goal of formulation development is to convert active substance (drug...
.jpg?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=A303EDE921EF0283547DD585579EDC71)
Targeted lipid nanoparticles in Nucleic Acid Delivery
Targeted lipid nanoparticles (tLNPs) enhance the precision and efficacy of delivering a variety of therapeutic agents including nucleic acids to specific tissues and cell populations, thereby...
Croda joins CGT Catapult consortium to improve AAV formulation
The Cell and Gene Therapy Catapult (CGT Catapult) has established a cross-industry consortium to improve the understanding and process optimisation of adeno-associated virus (AAV) formulation.
Synthesis, characterisation and degradation of polysorbates in biopharmaceuticals
Polysorbates are essential in biologics delivery, serving as crucial emulsifiers and stabilisers for biopharmaceuticals. They enhance solubility, improve bioavailability, and protect proteins from...